Ingo Paetsch

Ingo Paetsch

Auto-generated profile, based on publicly available information

Ingo Paetsch

Department of Electrophysiology, Heart Center Leipzig at University of Leipzig, Leipzig, Germany

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Heart Rhythm
Verified
Journal Article
Closed access
TSTimm Seewöster
Timm Seewöster
RSRicardo A. Spampinato
Ricardo A. Spampinato
PSPhilipp Sommer
Philipp Sommer
FLFrank Lindemann
Frank Lindemann
CJCosima Jahnke
Cosima Jahnke
JKJelena Kornej
Jelena Kornej

21 March 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
LULaura Ueberham
Laura Ueberham
AHAndreas Hagendorff
Andreas Hagendorff
KKKarin Klingel
Karin Klingel
IPIngo Paetsch
Ingo Paetsch
CJCosima Jahnke
Cosima Jahnke
BDBorislav Dinov
Borislav Dinov
Cardiac sarcoidosis can mimic any cardiomyopathy in different stages. Noncaseating granulomatous inflammation can be missed, because of the nonhomogeneous distribution in the heart. The current diagnostic criteria show discrepancies and are partly nonspecific and insensitive. Besides the diagnostic pitfalls, there are controversies in the understanding of the causes, genetic and environmental background, and the natural evolution of the disease. Here, we review the current pathophysiological aspects and gaps that are relevant for future cardiac sarcoidosis diagnostics and research.

27 January 2011 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Open access
PDF file
CJCosima Jahnke
Cosima Jahnke
JFJulia Fischer
Julia Fischer
JMJesus Gonzalez Mirelis
Jesus Gonzalez Mirelis
CKCharalampos Kriatselis
Charalampos Kriatselis
JGJin‐Hong Gerds‐Li
Jin‐Hong Gerds‐Li
IPIngo Paetsch
Ingo Paetsch
Purpose To prospectively determine the most reproducible approach for left‐atrial size assessment using cardiovascular magnetic resonance (CMR) imaging in patients with atrial fibrillation and its value for prediction of pulmonary vein isolation (PVI) treatment success. Materials and Methods Eighty patients underwent CMR imaging prior to PVI; the CMR examination included standard cine sequences, a multislice cine sequence in 4‐chamber orientation with full left‐atrial coverage, and a contrast‐enhanced MR angiography of the left atrium. Left‐atrial size was determined as: diameter, area, volume segmented from angiography, and diastolic/systolic volumes from cine imaging (Simpson's rule). All measurements were carried out by two independent observers and repeated by one observer to assess inter‐ and intrareader variability. Treatment success was defined as persisting sinus rhythm after PVI (follow‐up period 12.6 ± 6.6 months). Results All left‐atrial measurements showed substantial intrareader agreement. Interreader agreement was substantial for diastolic/systolic left‐atrial volumes only. Calculated bias was found to be minimal (0.1%–4.9%). Predictability of PVI treatment success was best using cine volumetric measurements (cutoff value for diastolic volume, 112 mL) yielding a sensitivity and specificity of 80% and 70%, respectively. Conclusion Left‐atrial volumetry based on cine imaging represented the most reproducible approach to determine left‐atrial size. PVI success was predicted best using cine volumetry. J. Magn. Reson. Imaging 2011;33:455–463.

30 December 2022 in EP Europace
Verified
Journal Article
Open access
PDF file
SRSergio Richter
Sergio Richter
RGRoman Gebauer
Roman Gebauer
MEMicaela Ebert
Micaela Ebert
CLCathleen Moscoso Ludueña
Cathleen Moscoso Ludueña
DSDominik Scheller
Dominik Scheller
MDMichael Döring
Michael Döring
Left bundle branch area pacing (LBBAP) can be technically challenging and fluoroscopy-intense. Three-dimensional electroanatomical mapping (EAM) facilitates non-fluoroscopic lead navigation and electrogram mapping. We sought to prospectively evaluate the feasibility, safety, and outcomes of routine EAM-guided LBBAP in patients with structural heart disease (SHD) and advanced conduction abnormalities. Consecutive patients with SHD and conduction abnormalities who underwent an attempt at EAM-guided LBBAP were included. The feasibility, safety, procedural, and mid-term outcomes were evaluated. Electrical, echocardiographic, and clinical parameters were assessed at implantation and last follow-up. Thirty-two patients (68 ± 18 years; 19% female) were included, of which 75% had intrinsic QRS > 150 ms, 53% left bundle branch block, and 25% right bundle branch block. Primary EAM-guided LBBAP was successful in 29 patients (91%). The procedural duration was 95 (70–110) min, total fluoroscopy time 0.93 (0.40–1.73) min, and total fluoroscopy dose 35.4 (20.5–77.2) cGy cm2. Paced QRS duration (QRSd) was significantly shorter than intrinsic QRSd (121.9 ± 10.7 vs. 159.2 ± 34.4 ms; P < 0.001) and remained stable during the mean follow-up of 7.0 ± 5.9 months. The LBBAP capture threshold was 0.57 ± 0.23 V/0.4 ms at implantation and remained low during follow-up (0.58 ± 0.18 V/0.5 ± 0.2 ms; P = 0.877). Overall left ventricular ejection fraction improved significantly from 44.2 ± 14.3% at baseline to 49.4 ± 13.1% at follow-up (P = 0.009), New York Heart Association class from 2.4 ± 0.6 to 1.8 ± 0.6 (P = 0.002), respectively. No complications occurred that required intervention. Routine near-zero fluoroscopy EAM-guided LBBAP can safely be performed in patients with SHD and advanced conduction abnormalities with high success rates and favourable mid-term outcomes. Further studies are needed to investigate whether the use of EAM improves the overall outcome of conduction system pacing and to identify specific patient populations who benefit the most from EAM-guided lead implantation.

16 October 2003 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Closed access
OGOlaf Grebe
Olaf Grebe
IPIngo Paetsch
Ingo Paetsch
HKHans Kestler
Hans Kestler
BHBernhard Herkommer
Bernhard Herkommer
BSBernhard Schnackenburg
Bernhard Schnackenburg
ENEike Nagel
Eike Nagel
The aim of this study was to simplify the imaging of myocardial infarction based on theoretical aspects and patient variables and to define the optimal time for image acquisition. Thirteen patients with chronic myocardial infarction underwent magnetic resonance imaging. After injection of 0.2 mmol/kg body weight Gd-DTPA an inversion recovery turbo gradient echo sequence with different prepulse delays was applied every 3 to 5 minutes within an interval of 3 to 30 minutes. As parameters of investigation, the area of signal enhancement and the contrast between enhanced and nonenhanced myocardium were used. There was no influence of prepulse delay or time after contrast injection on the enhanced area. The contrast between enhanced and normal myocardium showed a peak at 6 minutes post Gd-DTPA injection and remained high. The contrast between blood and enhanced myocardium was best at 6 and 25 minutes with best intra- and interobserver variability. In conclusion, if a suitable contrast was achieved, the area of enhancement is independent of prepulse delay or imaging time. In most patients the highest contrast between blood, enhanced and normal myocardium is achieved 6 minutes and 25 minutes after contrast injection.

3 June 2008 in Circulation
Verified
Journal Article
Closed access
MRMattias Roser
Mattias Roser
AHAshraf Hamdan
Ashraf Hamdan
TKTakeshi Komoda
Takeshi Komoda
CKCharalampos Kriatselis
Charalampos Kriatselis
PSPhilipp Stawowy
Philipp Stawowy
IPIngo Paetsch
Ingo Paetsch